Suppr超能文献

新型冠状病毒肺炎患者中急性冠状动脉综合征的发生率、临床特征、危险因素和结局:UMC-19-S10 研究结果。

Incidence, Clinical Characteristics, Risk Factors and Outcomes of Acute Coronary Syndrome in Patients With COVID-19: Results of the UMC-19-S10.

机构信息

Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

出版信息

J Emerg Med. 2022 Apr;62(4):443-454. doi: 10.1016/j.jemermed.2021.10.046. Epub 2021 Nov 3.

Abstract

BACKGROUND

There is a lack of knowledge about the real incidence of acute coronary syndrome (ACS) in patients with COVID-19, their clinical characteristics, and their prognoses.

OBJECTIVE

We investigated the incidence, clinical characteristics, risk factors, and outcomes of ACS in patients with COVID-19 in the emergency department.

METHODS

We retrospectively reviewed all COVID-19 patients diagnosed with ACS in 62 Spanish emergency departments between March and April 2020 (the first wave of COVID-19). We formed 2 control groups: COVID-19 patients without ACS (control A) and non-COVID-19 patients with ACS (control B). Unadjusted comparisons between cases and control subjects were performed regarding 58 characteristics and outcomes.

RESULTS

We identified 110 patients with ACS in 74,814 patients with COVID-19 attending the ED (1.48% [95% confidence interval {CI} 1.21-1.78%]). This incidence was lower than that observed in non-COVID-19 patients (3.64% [95% CI 3.54-3.74%]; odds ratio [OR] 0.40 [95% CI 0.33-0.49]). The clinical characteristics of patients with COVID-19 associated with a higher risk of presenting ACS were: previous coronary artery disease, age ≥60 years, hypertension, chest pain, raised troponin, and hypoxemia. The need for hospitalization and admission to intensive care and in-hospital mortality were higher in cases than in control group A (adjusted OR [aOR] 6.36 [95% CI 1.84-22.1], aOR 4.63 [95% CI 1.88-11.4], and aOR 2.46 [95% CI 1.15-5.25]). When comparing cases with control group B, the aOR of admission to intensive care was 0.41 (95% CI 0.21-0.80), while the aOR for in-hospital mortality was 5.94 (95% CI 2.84-12.4).

CONCLUSIONS

The incidence of ACS in patients with COVID-19 attending the emergency department was low, around 1.48%, but could be increased in some circumstances. Patients with COVID-19 with ACS had a worse prognosis than control subjects with higher in-hospital mortality.

摘要

背景

关于 COVID-19 患者中急性冠状动脉综合征(ACS)的实际发生率、临床特征及其预后,人们知之甚少。

目的

我们调查了急诊科 COVID-19 患者中 ACS 的发生率、临床特征、危险因素和结局。

方法

我们回顾性分析了 2020 年 3 月至 4 月间西班牙 62 家急诊科诊断为 ACS 的所有 COVID-19 患者(COVID-19 疫情的第一波)。我们设立了 2 个对照组:无 ACS 的 COVID-19 患者(对照组 A)和非 COVID-19 患者伴 ACS(对照组 B)。对病例和对照组之间 58 个特征和结局进行了未调整比较。

结果

我们在急诊科就诊的 74814 例 COVID-19 患者中发现 110 例 ACS(1.48%[95%可信区间 1.21-1.78%])。这一发生率低于非 COVID-19 患者(3.64%[95%CI 3.54-3.74%];比值比[OR]0.40[95%CI 0.33-0.49])。与 COVID-19 患者 ACS 发生率升高相关的临床特征为:既往冠状动脉疾病、年龄≥60 岁、高血压、胸痛、肌钙蛋白升高和低氧血症。与对照组 A 相比,病例组需要住院、入住重症监护病房和院内死亡的比例更高(校正比值比[aOR]6.36[95%CI 1.84-22.1]、aOR 4.63[95%CI 1.88-11.4]和 aOR 2.46[95%CI 1.15-5.25])。与对照组 B 相比,病例组入住重症监护病房的 aOR 为 0.41(95%CI 0.21-0.80),而院内死亡率的 aOR 为 5.94(95%CI 2.84-12.4)。

结论

急诊科就诊 COVID-19 患者 ACS 的发生率较低,约为 1.48%,但在某些情况下可能会升高。COVID-19 伴 ACS 的患者预后较对照组差,院内死亡率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a4/8563352/e49b6321be9d/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验